Hearst Corporation announced today that Charles Tuchinda, MD has been named president of FDB (First Databank). Tuchinda succeeds Gregory Dorn, MD, who is president of Hearst Health. The appointment was announced today by Steven R. Swartz, president and CEO of Hearst Corporation; Richard P. Malloch, president, Hearst Business Media; and Dorn, and is effective immediately.
“The volume, complexity and expense of medications on the market make expert drug knowledge more important than ever,” Malloch said. “For decades, FDB has been at the forefront of managing these challenges and Chuck has played a key role in helping drive our innovation and excellence in care guidance to the next level. He embodies a rare combination of talents as a business leader, innovator and physician, and we are privileged to have him on our team.”
Hearst Corporation announced today that Charles Tuchinda, MD has been named president of FDB (First Databank).
Most recently, Tuchinda was executive vice president of FDB, leading the product, information technology, data quality, clinical and editorial teams. Prior to his role at FDB, Tuchinda was Hearst Business Media’s chief innovation officer for healthcare. His work led to the commercialization of new products, including FDB AlertSpace.
Prior to joining Hearst, Tuchinda served as vice president of business development and product strategy at Eclipsys (now Allscripts), where he helped set the strategic direction and future roadmap. As the vice president of Acute Care Solutions, Tuchinda managed Eclipsys’s largest product line and helped the company achieve a Gartner Generation 3 rating. Earlier at Eclipsys, Tuchinda was vice president of content solutions, where he launched three product lines resulting in several million dollars in bookings within the first 18 months.
“Chuck has led FDB into new product domains that address significant healthcare challenges, such as interoperability, alert management and medication reconciliation,” Dorn said. “I am truly excited about Chuck leading FDB.”
“FDB makes an enormous impact across the entire spectrum of healthcare—from economics to patient safety to treatment outcomes,” Tuchinda said. “I am thrilled about what’s ahead as we offer leading and innovative solutions for high-quality, efficient care.”
Tuchinda completed his residency training at the Johns Hopkins Hospital and is board certified in internal medicine. He received an MBA from Harvard Business School, an MD from Johns Hopkins and a biomedical engineering degree from Harvard College.
FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions. As the company that virtually launched the medication decision support category, we offer more than three decades of experience in transforming drug knowledge into actionable, targeted, and effective solutions that improve patient safety and healthcare outcomes. For a complete look at our solutions and services, please visit www.fdbhealth.com or follow us on Twitter and LinkedIn.
About Hearst Health
FDB is part of the Hearst Health network, which also includes Zynx Health, MCG (formerly Milliman Care Guidelines) and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76 percent of discharged patients, 133 million insured individuals, 30 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab.